Answers are grounded in this paper and cite their sources.
Epidemiological evidence indicates that host genetic factors are relevant and predispose DHF/DSS development. Here, we review the host genetic studies concerning human leucocyte antigens, antibody receptors, immune/inflammatory mediators, attachment molecules, cytokines and other factors exerting an immunoregulatory effect as well as the current genome-wide association studies. We also discuss some viewpoints on future challenges related to the design of safe and effective prevention and treatment options.
No takes yet. Share an insight, caveat, or question.
Lan et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: